1 |
G. L. Vega. Results of experts meetings: obesity and cardiovascular disease. Obesity, the metabolic syndrome, and cardiovascular disease. Am Heart J. 142(6), p.1108-1116, 2001. DOI: http://dx.doi.org/10.1067/mhj.2001.119790
DOI
ScienceOn
|
2 |
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285(19), p.2486-2497, 2001. DOI: http://dx.doi.org/10.1001/jama.285.19.2486
DOI
ScienceOn
|
3 |
T. W. Yoo. Health yearbook. p.281-292, Seoul Bokuennews, 2000.
|
4 |
H. M. Kim, D. J. Kim, I. H. Jung, C. Park, J. Park. Prevalence of the metabolic syndrome among Korean adults using the new international diabetes federation definition and the new abdominal obesity criteria for the Korean people. Diabetes Res Clin Pract. 77, p.99-106, 2007 DOI: http://dx.doi.org/10.1016/j.diabres.2006.10.009
DOI
ScienceOn
|
5 |
D. D. Sin, L. Wu, S. F. Man. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 127(6), 1952-1959, 2005. DOI: http://dx.doi.org/10.1378/chest.127.6.1952
DOI
ScienceOn
|
6 |
F. Yeh, A. E. Dixon, L. G. Best, S. M. Marion, E. T. Lee, T. Ali, J. Yeh, E. R. Rhoades, B. V. Howard, R. B. Devereux. Lung function and heart disease in American Indian adults with high frequency of metabolic abnormalities (from the Strong Heart Study). Am J Cardiol. 114(2), p.312-319, 2014. DOI: http://dx.doi.org/10.1016/j.amjcard.2014.04.042
DOI
|
7 |
M. Dahl, A. Tybjaerg-Hansen, J. Vestbo, P. Lange, B. G. Nordestgaard. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 164(6), p.1008-1011, 2001. DOI: http://dx.doi.org/10.1164/ajrccm.164.6.2010067
DOI
ScienceOn
|
8 |
W. Jedrychowski, U. Maugeri, K. Gomola. B. Tobiasz-Adamczyk. Ventilatory lung function level as a predictor of survival among the elderly. Monaldi Arch Chest Dis. 49(4), p.293-297, 1994.
|
9 |
J. H. Chung, H. J. Hwang, C. H. Han, B. S. Son, D. H. Kim, M. S. Park. Association between Sarcopenia and Metabolic Syndrome in Chronic Obstructive Pulmonary Disease: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011. COPD. 2014 Jun 10. [Epub ahead of print] DOI: http://dx.doi.org/10.3109/15412555.2014.908835
|
10 |
Y. Yamamoto, J. Oya, T. Nakagami, Y. Uchigata. Association between lung function and metabolic syndrome independent of insulin in Japanese men and women. Jpn Clin Med. 5, p.1-8, 2014. DOI: http://dx.doi.org/10.1111/dme.12346
|
11 |
D. Yu, D. Simmons. Association between lung capacity measurements and abnormal glucose metabolism: findings from the Crossroads study. Diabet Med. 31(5), p.595-599. 2014.
DOI
|
12 |
M. Behnes, M. Brueckmann, V. Liebe, C. Liebetrau, S. Lang, C. Putensen, M. Borggrefe, U. Hoffmann. Levels of oxidized low-density lipoproteins are increased in patients with severe sepsis. J Crit Care. 23(4), p.537-541, 2008. DOI: http://dx.doi.org/10.1016/j.jcrc.2008.09.002
DOI
|
13 |
H. Santana, E. Zoico, E. Turcato, P. Tosoni, L. Bissoli, M. Olivieri, O. Bosello, M. Zamboni. Relation between body composition, fat distribution, and lung function in elderly men. Am J Clin Nutr. 73(4), p.827-331, 2001.
DOI
|
14 |
W. Jin, Y. Zhao, W. Yan, L. Cao, W. Zhang, M. Wang, T. Zhang, Q. Fu, Z. Li. Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis. Mediators Inflamm. 2012, p.10, 2012. DOI: http://dx.doi.org/10.1155/2012/506283
|
15 |
J. B. Sedgwick, Y. S. Hwang, H. A. Gerbyshak, H. Kita, W. W. Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes. Am J Respir Cell Mol Biol. 29(6), p.702-709, 2003. DOI: http://dx.doi.org/10.1165/rcmb.2002-0257OC
DOI
|
16 |
V. N. Bochkov, N. W. Leitinger. Anti-inflammatory properties of lipid oxidation products. J Mol Med (Berl). 81(10), p.613-26, 2003. DOI: http://dx.doi.org/10.1007/s00109-003-0467-2
DOI
|
17 |
W. G. Kuschner, A. D'Alessandro, H. Wong, P. D. Blanc. Dose dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 9(10), p.1989-94, 1996. DOI: http://dx.doi.org/10.1183/09031936.96.09101989
DOI
ScienceOn
|
18 |
P. Maestrelli, M. Saetta, C. E. Mapp, L. M. Fabbri. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 164(10 Pt 2), p.S76-80, 2001. DOI: http://dx.doi.org/10.1164/ajrccm.164.supplement_ 2.2106067
DOI
|
19 |
N. P. Kadoglou, G. Fotiadis, Z. Athanasiadou, I. Vitta, S. Lampropoulos, I. S. Vrabas. The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes. Endocrine. 42(3), p.561-569, 2012. DOI: http://dx.doi.org/10.1007/s12020-012-9650-y
DOI
|
20 |
F. S. Lira FS, J. C. Rosa, G. D. Pimentel, V. A. Tarini, R. M. Arida, F. Faloppa, E. S. Alves, C. O. do Nascimento, L. M. Oyama, M. Seelaender, M. T. de Mello, R. V. Santos. Inflammation and adipose tissue: effects of progressive load training in rats. Lipids Health Dis. 9, p.109, 2010.
DOI
|
21 |
R. Lazarus, C. J. Gore, M. Booth, N. Owen. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr. 68(1), p.35-41, 1998.
DOI
|
22 |
J. B. Schoenberg, G. J. Beck, A. Bouhuys. Growth and decay of pulmonary function in healthy blacks and whites. Respir Physiol. 33(3), p.367-393, 1978. DOI: http://dx.doi.org/10.1016/0034-5687(78)90063-4
DOI
ScienceOn
|
23 |
D. M. Mannino, E. S. Ford, S. C. Redd. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med. 254(6), 540-547, 2003. DOI: http://dx.doi.org/10.1111/j.1365-2796.2003.01211.x
DOI
|
24 |
D. D. Sin, S. F. Man. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases. The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 107(11), p.1514-1519, 2003. DOI: http://dx.doi.org/10.1161/01.CIR.0000056767.69054.B3
DOI
ScienceOn
|
25 |
Yong Il Hwang, Young Chul Kim, Jae Ho Lee, Min Jong Kang, Dong Gyu Kim. Symptom Questionnaire and Laboratory Findings in Subjects with Airflow Limitation: a Nation-wide Survey. Tuberc Respir Dis. 63, p.480-485, 2007. DOI: http://dx.doi.org/10.4046/trd.2007.63.6.480
과학기술학회마을
DOI
|
26 |
A. De Lorenzo, C. Maiolo, E. I. Mohamed, A. Andreoli, P. Petrone-De Luca, P. Rossi. Body composition analysis and changes in airways function in obese adults after hypocaloric diet. Chest. 119, p.1409-1415, 2001. DOI: http://dx.doi.org/10.1378/chest.119.5.1409
DOI
ScienceOn
|
27 |
M. Ohkita, M. Tawa, K. Kitada, Y. Matsumura. Pathophysiological Roles of Endothelin Receptors in Cardiovascular Diseases. J Pharmacol Sci. 119(4), p.302-313, 2012. DOI: http://dx.doi.org/10.1254/jphs.12R01CR
DOI
|